...
首页> 外文期刊>Circulation journal >Incidence and Significance of Spontaneous ST Segment Re-elevation After Reperfused Anterior Acute Myocardial Infarction ― Relationship With Infarct Size, Adverse Remodeling, and Events at 1 Year―
【24h】

Incidence and Significance of Spontaneous ST Segment Re-elevation After Reperfused Anterior Acute Myocardial Infarction ― Relationship With Infarct Size, Adverse Remodeling, and Events at 1 Year―

机译:再灌注前急性心肌梗死后自发性ST段抬高的发生及其意义ific与梗死面积,不良重塑和1年事件的关系

获取原文

摘要

Background: Up to 25% of patients with ST elevation myocardial infarction (STEMI) have ST segment re-elevation after initial regression post-reperfusion and there are few data regarding its prognostic significance. Methods?and?Results: A standard 12-lead electrocardiogram (ECG) was recorded in 662 patients with anterior STEMI referred for primary percutaneous coronary intervention (PPCI). ECGs were recorded 60–90 min after PPCI and at discharge. ST segment re-elevation was defined as a ≥0.1-mV increase in STMax between the post-PPCI and discharge ECGs. Infarct size (assessed as creatine kinase [CK] peak), echocardiography at baseline and follow-up, and all-cause death and heart failure events at 1 year were assessed. In all, 128 patients (19%) had ST segment re-elevation. There was no difference between patients with and without re-elevation in infarct size (CK peak [mean±SD] 4,231±2,656 vs. 3,993±2,819 IU/L; P=0.402), left ventricular (LV) ejection fraction (50.7±11.6% vs. 52.2±10.8%; P=0.186), LV adverse remodeling (20.1±38.9% vs. 18.3±30.9%; P=0.631), or all-cause mortality and heart failure events (22 [19.8%] vs. 106 [19.2%]; P=0.887) at 1 year. Conclusions: Among anterior STEMI patients treated by PPCI, ST segment re-elevation was present in 19% and was not associated with increased infarct size or major adverse events at 1 year.
机译:背景:高达25%的ST抬高型心肌梗塞(STEMI)患者在再灌注后初步消退后ST段重新抬高,关于其预后意义的数据很少。方法和结果:在662例因原发性经皮冠状动脉介入治疗(PPCI)进行的前STEMI患者中,记录了标准的12导联心电图(ECG)。 PPCI后和放电时60-90分钟记录心电图。 ST段再升高定义为PPCI后和放电ECG之间STMax≥0.1mV的增加。评估梗死面积(评估为肌酸激酶[CK]峰值),基线和随访时的超声心动图以及1年时的全因死亡和心力衰竭事件。共有128例患者(19%)发生了ST段抬高。梗死面积有无升高的患者之间无差异(CK峰值[平均值±SD] 4,231±2,656 vs. 3,993±2,819 IU / L; P = 0.402),左室(LV)射血分数(50.7± 11.6%vs. 52.2±10.8%; P = 0.186),LV不良重塑(20.1±38.9%vs. 18.3±30.9%; P = 0.631)或全因死亡率和心力衰竭事件(22 [19.8%] vs. 106 [19.2%]; P = 0.887)在1年时。结论:在接受PPCI治疗的前STEMI患者中,ST段再抬高的发生率为19%,并且与1年时的梗死面积增大或主要不良事件无关。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号